Sean Hawkey Photography

  • About
  • Contact
  • Photo Library
    • All Galleries
    • Search
    • Cart
    • Lightbox
    • Client Area
  • Video
  • Facebook
  • Twitter
x

Search Results

Refine Search
Match all words
Match any word
Prints
Personal Use
Royalty-Free
Rights-Managed
(leave unchecked to
search all images)
30 images found
twitterlinkedinfacebook

Loading ()...

  • A doctor wore PPE in the phase III clinical trials for Ebola virus disease vaccine in Guinea. The technique used was "ring vaccination" which was used in the 1970s to eliminate smallpox.
    Guinea_Hawkey_ebola_20150630_1639.jpg
  • The World Health Organisation is running phase III clinical trials for ebola virus disease vaccine in Guinea. The technique being used is "ring vaccination" which was used in the 1970s to eliminate smallpox.
    Guinea_Hawkey_ebola_20150630_1592.jpg
  • The bonnet of a vehicle of the World Health Organisation during the clinical trials for ebola virus disease vaccine in Guinea.
    Guinea_Hawkey_ebola_20150704_1600.jpg
  • The drill for destroying the Ebola virus where medical staff come in contact with confirmed cases is strict routine, one small mistake and the infection can be passed on. Staff in PPE, are often close to being overcome by the heat and dehydration, and sometimes need to be shouted instructions like "raise your head up" as each part of the drill is gone through, a series of specific movements as they are sprayed with a bleach solution and each part of the protective clothing is peeled off in the right order and in the right direction, and put straight in the incineration bucket, even the ground where they stand is considered contaminated and has to be covered in bleach. Eventually, a very grateful and completely sweat-sodden worker emerges from inside.
    Guinea_Hawkey_ebola_20150630_2093.jpg
  • Hadja Kakoro Sogbe and Halimatu Diallo, members of team nine of the WHO Ebola vaccine trials in Guinea, went through the extensive consent procedure with a participant in the Ebola vaccine trial. They wore protective clothing as the participants were all direct contacts of verified cases of Ebola.
    Guinea_Hawkey_ebola_20150630_1635.jpg
  • A poster from the Ebola ça Suffit campaign against Ebola in Guinea
    Guinea_Hawkey_ebola_20150630_2082.jpg
  • Dr. Sakoba Keita, coordinator of the Guinean Ebola Response spoke to local media during a village meeting on Ebola.
    Guinea_Hawkey_ebola_20150704_1689.jpg
  • Allasane Coumbassa, at the Conakry City Morgue. The morgue dealt with many Ebola deaths, Ousmane complained of inadequate protective measures, clothing or waste management to deal with the Ebola .
    Guinea_Hawkey_ebola_20150703_0025.jpg
  • Mamadouba Conté processed blood samples in the Ebola lab at Donka Hospital in Conakry, Guinea as part of the Ebola vaccine clinical trials.
    Guinea_Hawkey_ebola_20150629_0389.jpg
  • Dr. Sakoba Keita, coordinator of the Guinean Ebola Response spoke to local media during a village meeting on Ebola.
    Guinea_Hawkey_ebola_20150704_1800.jpg
  • A young woman in the village of Katongourou, western Guinea, an area heavily affected by Ebola. Many people in the village were participants in the WHO Ebola vaccine trial.
    Guinea_Hawkey_ebola_20150630_1844.jpg
  • During the phase III Ebola vaccine trial in Guinea, serum was separated from red blood cells for Ebola tests in Donka Hospital in Conakry, Guinea.
    Guinea_Hawkey_ebola_20150629_0134.jpg
  • A young man in Bonfe village, the first village in Guinea to take part in the Ebola vaccine trials that begin in March 2015.
    Guinea_Hawkey_ebola_20150702_0183.jpg
  • The phase III clinical trial of the Ebola vaccine in Guinea was hampered by difficulty in transport to remote regions.
    Guinea_Hawkey_ebola_20150702_0142.jpg
  • Team nine of the WHO Ebola vaccine trial at work in Guinea.
    Guinea_Hawkey_ebola_20150630_2019.jpg
  • rVSV Zebov-GP, the Ebola vaccine that was trialled in Guinea, ready to be administered to a participant in the clinical trial in Guinea.
    Guinea_Hawkey_ebola_20150630_1745.jpg
  • WHO staff prepared pharmaceuticals for participants in the clinical trials of the Ebola vaccine in Guinea.
    Guinea_Hawkey_ebola_20150629_0304.jpg
  • Fatoumata Conte, logisitics specialist for the WHO during the Ebola vaccine clinical trial in Conakry, Guinea.
    Guinea_Hawkey_ebola_20150703_0002.jpg
  • The phase III clinical trial of the Ebola vaccine in Guinea was hampered by difficulty in transport to remote regions.
    Guinea_Hawkey_ebola_20150702_0146.jpg
  • Mohamed Soumah, 27, the first person to be vaccinated in the Ebola vaccine trial. "It wasn't easy, I can't say I wasn't afraid, I was afraid. People in the village were saying that the injection was to kill me. I was the first one to be injected, the very first, here in my village on March 23. 44 people were vaccinated. I had fever after the vaccination, it worried me a bit, but they warned me that would happen and it didn't last long. I've been monitored for three months and I've had no problems. The last follow up, 84 days after the vaccination, was all clear".
    Guinea_Hawkey_ebola_20150702_0207.jpg
  • rVSV Zebov-GP, the Ebola vaccine that was trialled in Guinea, ready to be administered to a participant in the clinical trial in Guinea.
    Guinea_Hawkey_ebola_20150630_2102.jpg
  • A security guard in Guinea wears PPE and holds a thermo flash, a non-contact thermometer for testing at a road block. High temperature is the first major sign of Ebola infection, anyone with a temperature of 37 degrees celsius or above was stopped immediately for further testing and isolation to stop the spread of infections.
    Guinea_Hawkey_ebola_20150630_1848.jpg
  • Nene Aminata Diallo (l) and Gamou Saiman Gaston (r), carefully go through the consent process with a participant in the Ebola vaccine trial.
    Guinea_Hawkey_ebola_20150630_1954.jpg
  • While the Ebola vaccine was trialled it had to be kept at a temperature of minus 60 degrees celsius, these Arktek passive vaccine storage devices use jet fuel to keep the right temperature for up to five days in the field, even being opened several times a day. Here a vaccine core is being inserted into the device.
    Guinea_Hawkey_ebola_20150629_0252.jpg
  • Young men in Bonfe village, the first village in Guinea to take part in the Ebola vaccine trials that began in March 2015.
    Guinea_Hawkey_ebola_20150702_0017.jpg
  • rVSV Zebov-GP, the Ebola vaccine being prepared for injection.
    Guinea_Hawkey_ebola_20150630_2116.jpg
  • A security guard in Guinea wears PPE and holds a thermo flash, a non-contact thermometer for testing at a road block. High temperature is the first major sign of Ebola infection, anyone with a temperature of 37 degrees celsius or above was stopped immediately for further testing and isolation to stop the spread of infections.
    Guinea_Hawkey_ebola_20150630_2050.jpg
  • Karamoko Sonah Camara, head of a WHO Ebola vaccination trial team, prepared pharmaceuticals for the participants of the trial.
    Guinea_Hawkey_ebola_20150630_1958.jpg
  • Billo Mamadou Diallo, Karamoko Sonah Camara, Alain Mukendi, Jean Francoi Tolno and Hawa Madi, part of Team Nine of the WHO Ebola vaccine trial staff, at work in Katongourou, Guinea .
    Guinea_Hawkey_ebola_20150630_1661.jpg
  • Foromo Kpakpavogui, Ebola vaccine laboratory technician at Donka Hospital, Conakry, Guinea.
    Guinea_Hawkey_ebola_20150629_0191.jpg